Research Peptides · Cat. 011-22
BNP-32 (Canine)
Supplied as 200 µg per unit. Purity ≥ 95%. Molecular weight 3566.29. Species: Canine. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 011-22 |
|---|---|
| Product type | Research Peptides |
| Peptide family | Brain Natriuretic Peptide (BNP) |
| Species | Canine |
| Unit size | 200 µg |
| Molecular weight | 3566.29 Da |
| Purity | ≥ 95% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 200 µg of NET peptide. |
| Solubility | Soluble in water |
| Disulfide Bridge | Disulfide bridge(s): Cys10-Cys26 Analytical validation of commercial immunoassays for the measurement of cardiovascular peptides in the dog. Schellenberg S, Grenacher B, Kaufmann K, Reusch CE, Glaus TM. Vet J. 2008;178(1):85-90. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart. Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA. J Am Coll Cardiol. 2007;49(10):1079-88. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure. Chen HH, Huntley BK, Schirger JA, Cataliotti A, Burnett JC. J Am Soc Nephrol. 2006;17(10):2742-7. Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Tsuruda T, Boerrigter G, Huntley BK, et al. Circ Res. 2002;91(12):1127-34. |
| Research topics | Cardiovascular Research |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
Ser-Pro-Lys-Met-Met-His-Lys-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Lys-Tyr
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is BNP-32 (Canine)?
What purity is listed for 011-22?
How should BNP-32 (Canine) be stored?
What is the sequence of BNP-32 (Canine)?
What is the intended use of 011-22?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.